< Back to previous page

Publication

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Journal Contribution - Journal Article

Journal: Trials

ISSN: 1745-6215

Issue: 1

Volume: 21

Publication year:2020

WoS Id: 000605609400002
Handle: http://hdl.handle.net/1942/33304
DOI: https://doi.org/10.1186/s13063-020-04991-y

Accessibility:Open

See also: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study (vol 21, 1005, 2020)